Targeting apoptotic caspases in cancer

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Caspases are proteases critical for apoptosis, divided into initiator and executioner types.
• Conventional cancer therapies often induce apoptosis indirectly via caspases.
• Novel therapies aim to directly modulate caspase activity for cancer treatment.

Purpose of the Study:

• To review the roles of caspases in cancer, focusing on both apoptotic and non-apoptotic functions.
• To evaluate the therapeutic potential and limitations of targeting caspases in cancer treatment.
• To highlight the importance of considering non-apoptotic caspase roles for clinical efficacy.

Main Methods:

• Literature review of caspase family proteases.
• Analysis of apoptotic and non-apoptotic functions of caspases.
• Discussion of current and emerging cancer therapeutic strategies targeting caspases.

Main Results:

• Caspases are essential for apoptosis, with distinct initiator and executioner roles.
• Targeting caspases offers promise for novel cancer therapies, including gene therapy and small molecule inhibitors.
• Non-apoptotic functions of caspases present both opportunities and challenges for cancer treatment.

Conclusions:

• Caspase-mediated apoptosis is a central mechanism in cancer therapy.
• Emerging strategies focus on direct caspase activation or inhibition for enhanced anti-cancer effects.
• A comprehensive understanding of all caspase functions is vital for optimizing cancer treatment efficacy and safety.